Understanding dystrophinopathies: An inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse

Journal of Muscle Research and Cell Motility

Volumn 20, Issue 7, 1999, Pages 605-625

  Gillis, J M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ALPHA DYSTROBREVIN; CALCIUM; CALCIUM ION; DYSTROPHIN; GLYCOPROTEIN; MEMBRANE PROTEIN; MUSCLE PROTEIN; SARCOSPAN; SYNTROPHIN; UNCLASSIFIED DRUG; UTROPHIN;

AGE; ANIMAL MUSCULAR DYSTROPHY; APOPTOSIS; CALCIUM TRANSPORT; CYTOSOL; DUCHENNE MUSCULAR DYSTROPHY; ENERGY METABOLISM; HETEROZYGOSITY; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; MEMBRANE STRUCTURE; MITOCHONDRION; MUSCLE EXCITATION; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN METABOLISM; PROTEIN STRUCTURE; REVIEW; SARCOPLASMIC RETICULUM;

ANIMALS; DYSTROPHIN; MICE; MICE, INBRED MDX; MUSCULAR DYSTROPHIES;

ANIMALIA;

EID: 0033382340     PISSN: 01424319     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005545325254     Document Type: Review

References (208)

1. + channels in skeletal muscle fibres from normal and mutant mdx mice. J Physiol 498: 319-325.
2. 2+-activated neutral proteinase (calpain) in intact human platelets. Biochem J 289 (Pt 1): 93-99.
3. Anderson JE, Liu L and Kardami E (1991) Distinctive patterns of basic fibroblast growth factor (bFGF) distribution in degenerating and regenerating areas of dystrophic (mdx) striated muscles. Dev Biol 147: 96-109.
4. Anderson JE, Liu L and Kardami E (1994) The effects of hyperthyroidism on muscular dystrophy in the mdx mouse: greater dystrophy in cardiac and soleus muscle. Muscle Nerve 17: 64-73.
5. Baki A, Tompa P, Alexa A, Molnár O and Friedrich P (1996) Autolysis parallels activation of μ-calpain. Biochem J 318: 897-901.
6. 2+ levels in myotubes grown from skeletal muscle of dystrophic (mdx) and normal mice. J Physiol 460: 2-13.
7. Baumbach LL, Chamberlain JS, Ward PA, Farwell NJ and Caskey CT (1989) Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies. Neurology 39: 465-474.
8. Blake DJ, Tinsley JM and Davies KE (1996) Utrophin: a structural and functional comparison to dystrophin. Brain Pathol 6: 37-47.
9. Bodensteiner JB and Engel AG (1978) Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibres in 114 biopsies. Neurology 28: 439-446.
10. Boland B, Himpens B, Casteels R and Gillis JM (1993) Lack of dystrophin but normal calcium homeostasis in the smooth muscle from dystrophic mdx mice. J Muscle Res Cell Motil 14: 133-139.
11. Boland B, Himpens B, Denef JF and Gillis JM (1995) Site-dependent pathological differences in smooth muscles and skeletal muscles of the adult mdx mouse. Muscle Nerve 18: 649-657.
12. Brenman JE, Chao DS, Gee SH, McGee AW, Craven SE, Santillano DR, Wu Z, Huang F, Xia H, Peters MF, Froehner SC and Bredt DS (1996a) Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. Cell 84: 757-767.
13. Brenman JE, Chao DS, Xia H, Adalpe K and Bredt DS (1996b) Interaction of nitric oxide synthase complexed with dystrophin and absent from sarcolemma in Duchenne muscular dystrophy. Cell 82: 743-752.
14. Brocks L, Wirtz P, Loermans H and Binkhorst R (1992) Effects of early immobilization on the functional capacity of dystrophic (ReJ 129 dy/dy) mouse leg muscles. Int J Exp Pathol 73: 223-229.
15. Brooks SV (1998) Rapid recovery following contraction-induced injury to in situ skeletal muscles in mdx mice. J Muscle Res Cell Motil 19: 179-187.
16. Bulfield G, Siller WG, Wight PAL and Moore KJ (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 81: 1189-1192.
17. Carlson CG (1996) Acetylcholine receptor and calcium leakage activity in nondystrophic and dystrophic myotubes (MDX). Muscle Nerve 19: 1258-1267.
18. Carlson CG (1998) The dystrophinopathies: an alternative to the structural hypothesis. Neurobiol Dis 5: 3-15.
19. Carlson CG (1999) Spontaneous changes in acetylcholine receptor and calcium leakage activity in cell-attached patches from cultured dystrophic myotubes. Pflügers Arch/Eur J Physiol 437: 371-380.
20. Carlson CG and Makiejus RV (1990) A noninvasive procedure to detect muscle weakness in the mdx mouse. Muscle Nerve 13: 480-484.
21. Carlson CG and Officer T (1996) Single channel evidence for a cytoskeletal defect involving acetylcholine receptors and calcium influx in cultured dystrophic (mdx) myotubes. Muscle Nerve 19: 1116-1126.
22. Carnwath JW and Shotton DM (1987) Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles. J Neurol Sci 80: 39-54.
23. Carpenter JL, Hoffman EP, Romanul FC, Kunkel LM, Rosales RK, Ma NS, Dasbach JJ, Rae JF, Moore FM, and McAfee MB et al. (1989) Feline muscular dystrophy with dystrophin deficiency. Am J Pathol 135: 909-919.
24. Carter GT, Kikuchi N, Abresch RT, Walsh SA, Horasek SJ and Fowler WM Jr. (1994) Effects of exhaustive concentric and eccentric exercise on murine skeletal muscle. Arch Phys Med Rehabil 75: 555-559.
25. Carter GT, Wineinger MA, Walsh SA, Horasek SJ, Abresch RT and Fowler WM Jr. (1995) Effect of voluntary wheel-running exercise on muscles of the mdx mouse. Neuromuscul Disord 5: 323-332.
26. Cavagna GA and Margaria R (1966) Mechanics of walking. J Appl Physiol 21: 271-278.
27. Chang WJ, Iannaccone ST, Lau KS, Masters BS, McCabe TJ, McMillan K, Padre RC, Spencer MJ, Tidball JG and Stull JT (1996) Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc Natl Acad Sci USA 93: 9142-9147.
28. Chao DS, Rafael J, Gorospe M, Brenman JE, Rafael JA, Peters MF, Froehner SC, Hoffman EP, Chamberlain JS and Bredt DS (1996) Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy. J Exp Med 184: 609-618.
29. Chen BM and Grinnell AD (1995) Integrins and modulation of transmitter release from motor nerve terminals by stretch. Science 269: 1578-1580.
30. Clarke MSF, Khakee R and McNeil PL (1993) Loss of cytoplasmic basic fibroblast growth factor from physiologically wounded myofibers of normal and dystrophic muscle. J Cell Sci 106: 121-133.
31. Collet C, Allard B, Tourneur Y, Rougier O and Jacquemond V (1999) Indo-I calcium signals in skeletal musclr fibers from normal and mdx mice. Biophys J 76: A298.
32. Coulton GR, Curtin N, Morgan JE and Partridge TA (1988a) The mdx mouse skeletal muscle myopathy. II contractile properties. Neuropathol Appl Neurobiol 14: 299-314.
33. Coulton GR, Morgan JE, Partridge TA and Sloper JC (1988b) The mdx mouse skeletal muscle myopathy: I a histological, morphometric and biochemical investigation. Neuropathol Appl Neurobiol 14: 53-70.
34. Crosbie RH, Heighway J, Venzke DP, Lee JC and Campbell KP (1997) Sarcospan, the 25-kDa transmembrane component of the dystrophin-glycoprotein complex. J Biol Chem 272: 31221-31224.
35. Crosbie RH, Straub V, Yun HY, Lee JC, Rafael JA, Chamberlain JS, Dawson VL, Dawson TM and Campbell KP (1998a) mdx muscle pathology is independent of nNOS perturbation. Hum Mol Genet 7: 823-829.
36. Crosbie RH, Yamada H, Venzke DP, Lisanti MP and Campbell KP (1998b) Caveolin-3 is not an integral component of the dystrophin glycoprotein complex. FEBS Lett 427: 279-282.
37. Crosbie RH, Lebakken CS, Holt KH, Venzke DP, Straub V, Lee JC, Grady RM, Chamberlain JS, Sanes JR and Campbell KP (1999) Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex. J Cell Biol 145: 153-165.
38. Culligan KG, Mackey AJ, Finn DM, Maguire PB and Ohlendieck K (1998) Role of dystrophin isoforms and associated proteins in muscular dystrophy (Review). Int J Mol Med 2: 639-648.
39. Davison MD and Critchley DR (1988) Actinins and the DMD protein contain spectrin-like repeats. Cell 52: 159-160.
40. Deconinck N (1998) Functional evaluation of gene therapy in a mouse model of Duchenne muscular dystrophy. Ph.D.thesis, University of Louvain, Belgium.
41. Deconinck AE, Potter AC, Tinsley JM, Wood SJ, Vater R, Young C, Metzinger L, Vincent A, Slater CR and Davies KE (1997a) Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice. J Cell Biol 136: 883-894.
42. Deconinck AE, Rafael JA, Skinner JA, Brown SC, Potter AC, Metzinger L, Watt DJ, Dickson JG, Tinsley JM and Davies KE (1997b) Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90: 717-727.
43. Deconinck N, Ragot T, Maréchal G, Pérricaudet M and Gillis JM (1996) Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. Proc Natl Acad Sci USA 93: 3570-3574.
44. Deconinck N, Tinsley J, De Backer F, Fisher R, Kahn D, Phelps S, Davies K and Gillis JM (1997c) Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice. Nature Med 3: 1216-1221.
45. Deconinck N, Rafael JA, Beckers-Bleukx G, Kahn D, Deconinck AE, Davies KE and Gillis JM (1998) Consequences of the combined deficiency in dystrophin and utrophin on the mechanical properties and myosin composition of limb and respiratory muscles of the mouse. Neuromuscul Disord 8: 362-370.
46. De Luca A, Pierno S, Camerino C, Huxtable RJ and Camerino DC (1998) Effect of taurine on excitation-contraction coupling of extensor digitorum longus muscle of dystrophic mdx mouse. Adv Exp Med Biol 442: 115-119.
47. Denetclaw WF, Hopf FW, Cox GA, Chamberlain JS and Steinhardt RA (1994) Myotubes from transgenic mdx mice expressing full-length dystrophin show normal calcium regulation. Mol Biol Cell 5: 1159-1167.
48. DiMario JX, Uzman A and Strohman RC (1991) Fiber regeneration is not persitent in dystrophic (MDX) mouse skeletal muscle. Dev Biol 148: 314-321.
49. Dourdin N, Brustis JJ, Balcerzak D, Elamrani N, Poussard S, Cottin P and Ducastaing A (1997) Myoblast fusion requires fibronectin degradation by exteriorized m-calpain. Exp Cell Res 235: 385-394.
50. Duclos F, Straub V, Moore SA, Venzke DP, Hrstka RF, Crosbie RH, Durbeej M, Lebakken CS, Ettinger AJ, van der Meulen J, Holt KH, Lim LE, Sanes JR, Davidson BL, Faulkner JA, Williamson R and Campbell KP (1998) Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice. J Cell Biol 142: 1461-1471.
51. Duggan DJ, Gorospe JR, Fanin M, Hoffman EP and Angelini C (1997) Mutations in the sarcoglycan genes in patients with myopathy. N Engl J Med 336: 618-624.
52. Duncan CJ (1978) Role of intracellular calcium in promoting muscle damage: a strategy for controlling the dystrophic condition. Experientia 34: 1531-1535.
53. 2+ is elevated at all ages. J Neurol Sci 103: 1105-1110.
54. 31P-NMR study of muscle exercice metabolism in mdx mice: evidence for abnormal pH regulation. J Neurol Sci 113: 108-113.
55. Engel AG, Yamamoto M and Fishbeck KH (1994) Dystrophinopathies. In: Engel AG and Franzini-Armstrong C (eds) Myology: Basic and Clinical (pp 1133-1197) McGraw-Hill, New York.
56. England SB, Nicholson LV, Johnson MA, Forrest SM, Love DR, Zubrzycka-Gaarn EE, Bulman DE, Harris JB and Davies KE (1990) Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature 343: 180-182.
57. Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG and Campbell KP (1990) Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345: 315-319.
58. Ettinger AJ, Feng G and Sanes JR (1997) Epsilon-sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D. J Biol Chem 272: 32534-32538.
59. Even PC, Decrouy A and Chinet A (1994) Defective regulation of energy metabolism in mdx mouse skeletal muscles. Biochem J 304: 649-654.
60. Fabbrizio E, Bonet-Kerrache A, Limas F, Hugon G and Mornet D (1995) Dystrophin, the protein that promotes membrane resistance. Biochem Biophys Res Commun 213: 295-301.
61. Fardeau M, Tomé FMS, Collin H, Augier N, Pons F, Léger J and Léger JJ (1990) Présence d'une protéine de type dystrophine au niveau de la jonction neuromusculaire dans la dystrophie musculaire de Duchenne et la souris mutante 'mdx'. C R Acad Sci Paris 311: 197-204.
62. Fenichel GM, Florence JM, Pestronck A, Mendell JR, Moxley RC, Griggs RC, Brooke MH, Miller JP, Robinson J and King W (1991) Long term benefit from prednisone therapy in Duchenne muscular dystrophy. Neurology 41: 1874-1877.
63. Feron O, Dessy C, Opel DJ, Arstall MA, Kelly RA and Michel T (1998) Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rale. J Biol Chem 273: 30249-30254.
64. Fong P, Turner PR, Denetclaw WF and Steinhardt RA (1990) Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin. Science 250: 673-676.
65. Foster AH and Carlson BM (1980) Myotoxicity of local anesthetics and regeneration of the damaged muscle fibers. Anesthes Analg 59: 727-736.
66. Foxley A, Edwards RHT and Jackson MJ (1991) Enhanced lipid peroxidation in Duchenne muscular dystrophy may be secondary to muscle damage. Biochem Soc Trans 19: 180S.
67. Franco A and Lansman JB (1990) Calcium entry through stretch-inactivated ion channels in mdx myotubes. Nature 344: 670-673.
68. Friedrich O, Ehmer T and Fink R (1999) Calcium currents during contraction and shortening in enzymatically isolated murine skeletal muscle fibres. J Physiol 517: 757-770.
69. Gailly P, Boland B, Himpens B, Casteels R and Gillis JM (1993a) Critical evaluation of cytosolic calcium determination in resting muscle fibres from normal and dystrophic (mdx) mice. Cell Calcium 14: 473-483.
70. Gailly P, Hermans E, Octave JN and Gillis JM (1993b) Specific increase of genetic expression of parvalbumin in fast skeletal muscle of mdx mice. FEBS Lett 326: 272-274.
71. 2+ entry coupling' in fibroblast expressing the rat neurotensin receptor. J Physiol 491: 625-636.
72. Gaschen FP, Hoffman EP, Gorospe JR, Uhl EW, Senior DF, Cardinet GH and Pearcc LK (1992) Dystrophin deficiency causes lethal muscle hypertrophy in cats. J Neurol Sci 110: 149-159.
73. Gillis JM (1996a) The mdx mouse: why diaphragm? Muscle Nerve 19: 1230.
74. Gillis JM (1996b) Membrane abnormalities and Ca homeostasis in muscles of the mdx mouse, an animal model of the Duchenne muscular dystrophy: a review. Acta Physiol Scand 156: 397-406.
75. Gossrau R (1998) Nitric oxide synthase I (NOS I) is a costameric enzyme in rat skeletal muscle. Acta Histochem 100: 451-462.
76. 31P NMR study. Neuromuscul Disord 8: 371-379.
77. Grady RM, Merlie JP and Sanes JR (1997) Subtle neuromuscular defects in utrophin-deficient mice. J Cell Biol 136: 871-882.
78. Grady RM, Teng H, Nichol MC, Cunningham JC, Wilkinson RS and Sanes JR (1997) Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 99: 729-738.
79. Hack AA, Ly CT, Jiang F, Clendenin CJ, Sigrist KS, Wollmann RL and McNally EM (1998) Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. J Cell Biol 142: 1279-1287.
80. Hall-Craggs EC (1974) Rapid degeneration and regeneration of a whole skeletal muscle following treatment with bupivacaine (Marcain). Exp Neurol 43: 349-358.
81. Hassoni H, Brown AE and Harris JB (1996) Calcium and Duchenne muscular dystrophy. J Physiol 491: 129P.
82. Haws CM and Lansman JB (1991) Developmental regulation of mechanosensitive calcium channels in skeletal muscle from normal and mdx mice. Proc Roy Soc Lond B 245: 173-177.
83. Head SI (1993) Membrane potential, resting calcium and calcium transients in isolated muscle fibres from normal and dystrophic mice. J Physiol 469: 11-19.
84. Hocherman SD and Bezanilla F (1996) A patch-clamp study of delayed rectifier currents in skeletal muscle of control and mdx mice. J Physiol 493: 113-128.
85. Hoffman EP, Brown RH and Kunkel LM (1987a) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51: 919-928.
86. Hoffman EP, Knudson CM, Campbell KP and Kunkel LM (1987b) Subcellular fractionation of dystrophin to the triads of skeletal muscle. Nature 330: 754-758.
87. Hollingworth S, Marshall MW and Robson E (1990) Excitation contraction coupling in normal and mdx mice. Muscle Nerve 13: 16-20.
88. Hopf FW, Turner PR, Denetclaw WF, Reddy P and Steinhardt RA (1996) A critical evaluation of resting intracellular free calcium regulation in dystrophic mdx muscle. Am J Physiol 271: C1325-C1339.
89. Hutter OF, Burton FL and Bovell DL (1991) Mechanical properties of normal and mdx sarcolemma: bearing on function of dystrophin. J Muscle Res Cell Motil 12: 585-589.
90. Imbert N, Cognard C, Duport G, Guillou C and Raymond G (1995) Abnormal calcium homeostasis in Duchenne muscular dystrophy myotubes contracting in vitro. Cell Calcium 18: 177-186.
91. Imbert N, Vandebrouck C, Constantin B, Duport G, Guillou C, Cognard C and Raymond G (1996) Hypoosmotic shocks induce elevation of resting calcium level in Duchenne muscular dystrophy myotubes contracting in vitro. Neuromusc Disord 6: 351-360.
92. Ingber DE (1993) Cellular tensegrity: defining new rules of biological design that govern the cytoskeleton. J Cell Sci 104: 613-627.
93. Ingber DE (1997) Tensegrity: the architectural basis of cellular mechanotransduction. Ann Rev Physiol 59: 575-599.
94. Ingber DE, Dike L, Hansen L, Karp S, Liley H, Maniolis A, McNamee H, Mooney D, Plopper G and Sims J et al. (1994) Cellular tensegrity: exploring how mechanical changes in the cytoskeleton regulate cell growth, migration, and tissue pattern during morphogenesis. Int Rev Cytol 150: 173-224.
95. Isaacs ER, Bradley WG and Henderson G (1973) Longitudinal fibre splitting in muscular dystrophy: a serial cinematographic study. J Neurol Neurosurg Psychiatry 36: 813-819.
96. James M, Nguyen TM, Wise CJ, Jones GE and Morris GE (1996) Utrophin-dystroglycan complex in membranes of adherent cultured cells. Cell Motil Cytoskeleton 33: 163-174.
97. Jasmin BJ, Alameddine H, Lunde JA, Stetzkowski-Marden F, Collin H, Tinsley JM, Davies KE, Tomé FM, Parry DJ and Cartaud J (1995) Expression of utrophin and its mRNA in denervated mdx mouse muscle. FEBS Lett 374: 393-398.
98. Jockusch H, Friedrich G and Zippel M (1990) Serum parvalbumin, an indicator of muscle disease in murine dystrophy and myotonia. Muscle Nerve 13: 551-555.
99. Kämper A and Rodemann HP (1992) Alterations of protein degradation and 2-D protein pattern in muscle cells of MDX and DMD origin. Biochem Biophys Res Commun 189: 1484-1490.
100. Kampfl A, Posmantur R, Nixon R, Grynspan F, Zhao X, Liu SJ, Newcomb JK, Clifton GE and Hayes RL (1996) mu-calpain activation and calpain-mediated cytoskeletal proteolysis following traumatic brain injury. J Neurochem 67: 1575-1583.
101. 2+ on binding of the calpains to calpastatin. J Biol Chem 264: 17888-17896.
102. Kargacin ME and Kargacin GJ (1996) The sarcoplasmic reticulum calcium pump is functionally altered in dystrophic muscles. Biochim Biophys Acta 1290: 4-8.
103. Karpati G and Carpenter S (1986) Small-caliber skeletal muscle fibers do not suffer deleterious consequences of dystrophic gene expression. Am J Med Genet 25: 653-658.
104. Karpati G, Carpenter S and Prescott S (1988) Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy. Muscle Nerve 11: 795-803.
105. Karpati G, Zubrzycka-Gaarn EE, Carpenter S, Bulman DE, Ray PN and Worton RG (1990) Age-related conversion of dystrophin-negative to -positive fiber segments of skeletal but not cardiac muscle fibers in heterozygote mdx mice. J Neuropathol Exp Neurol 49: 96-105.
106. Kelly AM (1978) Sattelite cells and myofiber growth in the rat soleus and extensor digitorum longus muscles. Dev Biol 65: 1-10.
107. Khurana TS, Hoffman EP and Kunkel LM (1990) Identification of a chromosome 6-encoded dystrophin-related protein. J Biol Chem 265: 16717-16720.
108. Khurana TS, Watkins SC, Chafey P, Chelly J, Tomé FM, Fardeau M, Kaplan JC and Kunkel LM (1991) Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle. Neuromuscul Disord 1: 185-194.
109. Khurana TS, Prendergast RA, Alameddine HS, Tomé FM, Fardeau M, Arahata K, Sugita H and Kunkel LM (1995) Absence of extraocular muscle pathology in Duchenne's muscular dystrophy: role for calcium homeoslasis in extraocular muscle sparing. J Exp Med 182: 467-475.
110. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP and Kunkel LM (1987) Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50: 509-517.
111. Kometani K, Tsugeno H and Yamada K (1990) Mechanical and energetic properties of dystrophic (mdx) mouse muscle. Jpn J Physiol 40: 541-549.
112. Kramer R, Lochmuller H, Abicht A, Rudel R and Brinkmeier H (1998) Myotonic ADR-MDX mutant mice show less severe muscular dystrophy than MDX mice. Neuromuscul Disord 8: 542-550.
113. Kunkel LM and Hoffman EP (1989) Duchenne/Becker muscular dystrophy: a short overview of the gene, the protein, and current diagnostics. Br Med Bull 45: 630-643.
114. Kuznetsov AV, Winkler K, Wiedemann FR, von Bossanyi P, Dietzmann K and Kunz WS (1998) Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse. Mol Cell Biochem 183: 87-96.
115. Law DJ, Allen DL and Tidball JG (1994) Talin, vinculin and DRP (utrophin) concentrations are increased at mdx myotendinous junctions following onset of necrosis. J Cell Sci 107: 1477-1483.
116. Law DJ, Caputo A and Tidball JG (1995) Site and mechanics of failure in normal and dystrophin-deficient skeletal muscle. Muscle Nerve 18: 216-223.
117. Law DJ and Tidball JG (1993) Dystrophin deficiency is associated with myotendinous junction defects in prenecrotic and fully regenerated skeletal muscle. Am J Pathol 142: 1513-1523.
118. 2+ sequestration by the sarcoplasmic reticulum of fast and slow muscles in normal and dystrophic mice. Eur J Biochem 174: 247-253.
119. Leijendekker WJ, Passaquin AC, Metzinger L and Rüegg UT (1996) Regulation of cytosolic calcium in skeletal muscle cells of the mdx mouse under conditions of stress. Br J Pharmacol 118: 611-616.
120. Liberona JL, Powell JA, Shenoi S, Petherbridge L, Caviedes R and Jaimovich E (1998) Differences in both inositol 1,4,5-trisphosphate mass and inositol 1,4,5-trisphosphate receptors between normal and dystrophic skeletal muscle cell lines. Muscle Nerve 21: 902-909.
121. Lucas-Heron B (1996) Absence of a calmitine-specific protease inhibitor in skeletal muscle mitochondria of patients with Duchenne's muscular dystrophy. Biochem Biophys Res Commun 225: 701-704.
122. Lucas-Heron B, Schmitt N and Ollivier B (1990a) Calmitine: a calcium-binding mitochondrial protein specific for fast-twitch muscle fibers. Neurosci Lett 115: 103-107.
123. Lucas-Heron B, Schmitt N and Ollivier B (1990b) Muscular dystrophy: possible role of mitochondrial deficiency in muscle degeneration processes. J Neurol Sci 95: 327-334.
124. Lucas-Heron B, Schmitt N and Ollivier B (1994) Mdx mouse skeletal muscle: could a mitochondrial factor be responsible for the absence of progressive necrosis? Neurosci Lett 169: 97-100.
125. Lyons PR and Slater CR (1991) Structure and function of the neuromuscular junction in young adult mdx mice. J Neurocytol 20: 969-981.
126. MacLennan PA and Edwards RHT (1990) Protein turnover is elevated in muscles of mdx mice in vivo. Biochem J 268: 795-797.
127. MacLennan PA, McArdle A and Edwards RH (1991) Effects of calcium on protein turnover of incubated muscles from mdx mice. Am J Physiol 260: E594-E598.
128. Maréchal G and Beckers-Bleukx G (1988) Force-velocity and myosin isozymes in muscles of dystrophic (mdx) mice. Arch Int Physiol Biochim 96: P16.
129. Mathes C, Bezanilla F and Weiss RE (1991) Sodium current and membrane potential in EDL muscle fibers from normal and dystrophic (mdx) mice. Am J Physiol 261: C718-C725.
130. Matsubara I, Goldman YE and Simmons RM (1984) Changes in the lateral filament spacing of skinned muscle fibres when cross-bridges attach. J Mol Biol 173: 15-33.
131. Matsuda R, Nishikawa A and Tanaka H (1995) Visualization of dystrophic muscle fibres in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. J Biochem 118: 959-964.
132. Matsumura K and Campbell KP (1994) Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Muscle Nerve 17: 2-15.
133. Matsumura K, Ervasti J, Ohlendieck K, Kahl S and Campbell K (1993) Association of dystrophin-related protein with dystrophin associated proteins in mdx mouse muscle. Nature 360: 588-591.
134. McArdle A and Jackson MJ (1996) Heat shock protein 70 expression in skeletal muscle. Biochem Soc Trans 24: 485S.
135. McArdle A, Edwards RHT and Jackson MJ (1991) Effects of the contractile activity on muscle damage in the dystrophin-deficient mdx mice. Clin Sci 80: 367-371.
136. McArdle A, Edwards RHT and Jackson MJ (1992) Accumulation of calcium by normal and dystrophin-deficient mouse muscle during contractile activity in vitro Clin Sci 82: 455-459.
137. McArdle A, Edwards RHT and Jackson MJ (1994) Time course of changes in plasma membrane permeability in the dystrophin-deficient mdx mouse. Muscle Nerve 17: 1378-1384.
138. McArdle A, Helliwell TR, Beckett GJ, Catapano M, Davis A and Jackson MJ (1998) Effect of propylthiouracil-induced hypothyroidism on the onset of skeletal muscle necrosis in dystrophin-deficient mdx mice. Clinical Sciences 95: 83-89.
139. McCarter GC, Denetclaw WF, Reddy P and Steinhardt RA (1997) Lipofection of a cDNA plasmid containing the dystrophin gene lowers intracellular free calcium and calcium leak channel activity in mdx myotubes. Gene Ther 4: 483-487.
140. Menke A and Jockusch H (1991) Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse. Nature 349: 69-71.
141. Metzinger L, Blake DJ, Squier MV, Anderson LV, Deconinck AE, Nawrotzki R, Hilton-Jones D and Davies KE (1997) Dystrobrevin deficiency at the sarcolemma of patients with muscular dystrophy. Hum Mol Genet 6: 1185-1191.
142. Mizumo Y (1992) Prevention of myonecrosis in mdx mice: effect of immobilization by the local tetanus method. Brain Dev 14: 319-322.
143. Mizumo Y, Nonaka I, Hirai S and Ozawa E (1993) Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD carriers and control subjects. J Neurol Sci 119: 43-52.
144. Moens P, Baatsen PHWW and Maréchal G (1993) Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch. J Muscle Res Cell Motil 14: 446-451.
145. Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H and Kunkel LM (1988) An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 2: 90-95.
146. 2+ at rest and after cholinergic stimulus is increased in cultured muscle cells from Duchenne muscular dystrophy patients. Neurology 38: 476-480.
147. Nagel A, Lehmann-Horn F and Engel AG (1990) Neuromuscular transmission in the mdx mouse. Muscle Nerve 13: 742-749.
148. Ohlendieck K and Campbell KP (1991a) Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J Cell Biol 115: 1685-1694.
149. Ohlendieck K and Camphell KP (1991b) Dystrophyn constitutes 5% of membrane cytoskeleton in skeletal muscle. FEBS Lett 283: 230-234.
150. Pardo JV, Siliciano JD and Craig SW (1983) A vinculin-containing cortical lattice in skeletal muscle: transverse lattice elements (costameres) mark sites of attachment between myofibrils and sarcolemma. Proc Natl Acad Sci USA 80: 1008-1012.
151. Pasternack C, Wong S and Elson EL (1995) Mechanical function of dystrophin in muscle cells. J Cell Biol 128: 355-361.
152. Pastoret C and Sebille A (1995) mdx mice show progressive weakness and muscle deterioration with age. J Neurol Sci 129: 95-107.
153. Péréon Y, Khammari A and Noireaud J (1996) Perchlorate differentially potentiates excitation-contraction coupling of diaphragm muscle from mdx and control mice. Acta Physiol Scand 158: 287-294.
154. Pete D and Vrbova G (1992) Adaptation of mamalian skeletal muscle fibers to chronic electrical stimulation. Rev Physiol Biochem Pharmacol 120: 116-202.
155. Petrof BJ, Shrager JB, Stedman HH, Kelly AM and Sweeney HL (1993) Dystrophin protects the sarcoiemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 90: 3710-3714.
156. Poussard S, Cottin P, Brustis JJ, Talmat S, Elamrani N and Ducastaing A (1993) Quantitative measurement of calpain I and II mRNAs in differentiating rat muscle cells using a competitive polymerase chain reaction method. Biochimie 75: 885-890.
157. 2+ concentrations are not elevated in resting cultured muscle from Duchenne (DMD) patients and in MDX mouse muscle fibres. Pflügers Arch 426: 499-505.
158. 2+ handling and survival in mdx skeletal muscle cells. FEBS Lett 439: 357-362.
159. Putney JW Jr (1990) Capacitative calcium entry revisited. Cell Calcium 11: 611-624.
160. Quinlan JG, Johnson SR and Samaha FJ (1990) Dantrolene normalizes serum creatine kinase in MDX mice [letter]. Muscle Nerve 13: 268-269.
161. Reeve JL, McArdle A and Jackson MJ (1997) Age-related changes in muscle calcium content in dystrophin-deficient mdx muscle. Muscle Nerve 20: 357-360.
162. Remmers JE (1976) Analysis of ventilatory responses. Chest 70 (suppl.): 134-137.
163. Rivet-Bastide M, Imbert N, Cognard C, Duport G, Rideau Y and Raymond G (1993) Changes in cytosolic resting ionized calcium level and in calcium transients during in vitro development of normal and Duchenne muscular dystrophy cultured skeletal muscle measured by laser cytofluorimetry using Indo-I. Cell Calcium 14: 563-571.
164. 2+ revealed by specifically targeted recombinant aequorin. Nature 358: 325-327.
165. Rosenblatt JD and Woods RI (1992) Hypertrophy of rat extensor digitorum longus muscle injected with bupivacaine. A sequential histochemical, immunohistochemical, hislological and morphometric study. J Anal 181: 11-27.
166. Rybakova IN, Amann KJ and Ervasti JM (1996) A new model for the interaction of dystrophin with F-actin. J Cell Biol 135: 661-672.
167. Rybakova IN and Ervasti JM (1997) Dystrophin-glycoprotein complex is monomeric and stabilizes actin filaments in vitro through a lateral association. J Biol Chem 272: 28771-28778.
168. Sacco P, Jones DA, Dick JRT and Vrbova G (1992) Contractile properties and susceptibility to exercise-induced damage of normal and mdx mouse libialis anterior muscle. Clin Sci 82: 227-236.
169. Sandri M, Podhorska-Okolov M, Geromel V, Rizzi C, Arslan P, Franceschi C and Carraro U (1997) Exercise induces myonuclear ubiquitination and apoptosis in dystrophin-deficient muscle of mice. J Neuropathol Exp Neurol 56: 45-57.
170. Sandri M, Minetti C, Pedemonte M and Carraro U (1998) Apoptotic myonuclei in human Duchenne muscular dystrophy. Lab Invest 78: 1005-1016.
171. Sano M, Wada Y, Ii K, Kominami E, Katunuma N and Tsukagoshi H (1988) Immunolocalization of cathepsins B, H and L in skeletal muscle of X-linked muscular dystrophy (mdx) mouse. Acta Neuropathol (Berl) 75: 217-225.
172. Sawada H, Tsuji S. Kusumoto S, Doi Y and Matsuhita H (1986) Preclinical increase in activity of muscle microsomal trypsin-like protease in murine muscular dystrophy, C57BL/10-mdx. FEBS Lett 199: 193-197.
173. 2+-activated protease in myoblast fusion. Exp Cell Res 162: 411-422.
174. Schotland DL, Bonilla E and Van Meter M (1977) Duchenne dystrophy: alteration in muscle plasma membrane structure. Science 196: 1005-1007.
175. Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG and Barnard BJ (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244: 1578-1580.
176. Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS and Lisanti MP (1996) Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 271: 15160-15165.
177. Spencer MJ and Tidball JG (1992) Calpain concentration is elevated although! net calcium-dependent proteolysis is suppressed in dystrophin-deficient muscle. Exp Cell Res 203: 107-114.
178. Spencer MJ and Tidball JG (1996) Calpain translocation during muscle fiber necrosis and regeneration in dystrophin-deficient mice. Exp Cell Res 226: 264-272.
179. Spencer MJ, Croall DE and Tidball JG (1995) Calpains are activated in necrotic fibers from mdx dystrophic mice. J Biol Chem 270: 10909-10914.
180. Spencer MJ, Walsh CM, Dorshkind KA, Rodriguez R and Tidball JG (1997) Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity. J Clin Invest 99: 2745-2751.
181. Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panetteri RA, Petrof B, Narusawa M, Leferovich JM, Sladky JT and Kelly AM (1991) The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352: 536-539.
182. Straub V, Bittner RE, Léger JJ and Voit T (1992) Direct visualization of the dystrophin network on skeletal muscle fiber membrane. J Cell Biol 119: 1183-1191.
183. Street SF (1983) Lateral transmission of tension in frog myofibers: a myofibrillar network and transverse cytoskeletal connections are possible transmitters. J Cell Physiol 114: 346-364.
184. Sunada Y and Campbell K (1995) Dystrophin-glycoprotein complex: molecular organization and critical roles in skeletal muscle. Curr Opin Neurol 8: 379-384.
185. Takagi A, Kojima S, Ida M and Araki M (1992) Increased leakage of calcium ion from the sarcoplasmic reticulum of the mdx mouse. J Neurol Sci 110: 160-164.
186. Takemitsu M, Ishiura S, Koga R, Kamakura K, Arahata K, Nonaka T and Sugita H (1991) Dystrophin-related protein in the fetal and denervated skeletal muscles of normal and mdx mouse. Biochem Biophys Res Comm 180: 1179-1186.
187. Talbot JA and Morgan DL (1998) The effects of stretch parameters on eccentric exercise-induced damage to toad skeletal muscle. J Muscle Res Cell Motil 19: 237-245.
188. Tidball JG (1991) Force transmission across muscle cell membranes. J Biomech 24 (suppl.I): 43-52.
189. Tidball JG and Law DJ (1991) Dystrophin is required for normal thin filament-membrane associations at myotendinous junctions. Am J Pathol 138: 17-21.
190. Tidball JG, Albrecht DE, Lokensgard BE and Spencer MJ (1995) Apoptosis precedes necrosis of dystrophin-deficient muscle. J Cell Sci 108: 2197-2204.
191. Tinsley JM, Blake DJ, Roche A, Fairbrother U, Riss J, Byth BC, Knight AE, Kendrick-Jones J, Suthers GK, Love DR, Edwards YH and Davies KE (1992) Primary structure of dystrophin-related protein. Nature 360: 591-602.
192. Tinsley JM and Davies KE (1993) Utrophin: a potential replacement for dystrophin? Neuromusc Disord 3: 537-539.
193. Turner PR, Westwood T, Regen CM and Steinhardt RA (1988) Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Nature 355: 735-738.
194. Turner PR, Fong P, Denetclaw WF and Steinhardt RA (1991) Increased calcium influx in dystrophic muscle. J Cell Biol 115: 1701-1712.
195. Turner PR, Schultz R, Ganguly B and Steinhardt RA (1993) Proteolysis results in altered leak channel kinetics and elevated free calcium in mdx muscle. J Membr Biol 133: 243-251.
196. Tutdibi O, Brinkmeier H, Rudel R and Fohr KJ (1999) Increased calcium entry into dystrophin-deficient muscle fibres of MDX and ADR-MDX mice is reduced by ion channel blockers. J Physiol 515: 859-868.
197. Vaghy PL, Fang J, Wu W and Vaghy LP (1998) Increased caveolin-3 levels in mdx mouse muscles. FEBS Lett 431: 125-127.
198. Valentine BA, Winand NJ and Pradhan D (1992) Canine X-linked muscular dystrophy as an animal model of Duchenne muscular dystrophy. Am J Med Genet 42: 352-356.
199. Wakayama Y and Shibuya S (1990) Observation on the muscle plasma membrane-associated cytoskeletons of mdx mice by quick-freez, deep etch, rotary-shadow replica method. Acta Neuropathol 80: 618-623.
200. Wakeford S, Watt DJ and Partridge TA (1991) X-irradiation improves mdx mouse muscle as a model of myofiber loss in DMD. Muscle Nerve 14: 42-50.
201. Wang N, Butler JP and Ingber DE (1993) Mechanotransduction across the cell surface and through the cytoskeleton. Science 260: 1124-1127.
202. Webster C, Silberstein L, Hays AP and Blau HM (1988) Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell 52: 502-513.
203. Weller B, Karpati G, Lehnen S and Carpenter S (1991a) Major alteration of the pathological phenotype in gamma irradiated mdx soleus muscles. J Neuropathol Exp Neurol 50: 419-431.
204. Weller B, Massa R, Karpati G and Carpenter S (1991b) Glucocorticoids and immunosuppressants do not change the prevalence of necrosis and regeneration in mdx skeletal muscles. Muscle Nerve 14: 771-774.
205. Winder SJ (1997) The membrane-cytoskeleton interface: the role of dystrophin and utrophin. J Muscle Res Cell Motil 18: 617-629.
206. 2 terminal F-actin binding domain of utrophin. FEBS Lett 357: 125-128.
207. Winder SJ, Gibson TJ and Kendrick-Jones J (1995) Dystrophin and utrophin: the missing links! FEBS Lett 369: 27-33.
208. Zubrzycka-Gaarn EE, Bulman DE, Karpali G, Burghes AHM, Belfall B, Klamut HJ, Talbot J, Hodges RS, Ray PN and Worton RG (1988) The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature 333: 466-469.